Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Kennedy

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Infection and Immunity|December 4, 2019
ZBTB7B (ThPOK) Is Required for Pathogenesis of Cerebral Malaria and Protection against Pulmonary TuberculosisJames M Kennedy, Anna Georges, Angelia V Bassenden, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Rocaglates as dual-targeting agents for experimental cerebral malariaDavid Langlais, Regina Cencic, Neda Moradin, et al.
The Journal of Experimental Medicine|November 19, 2014
CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammationJames M Kennedy, Nassima Fodil, Sabrina Torre, et al.
Nature Immunology|October 11, 2016
USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammationSabrina Torre, Maria J Polyak, David Langlais, et al.
The Lancet. Gastroenterology & Hepatology|September 1, 2020
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry studyGwilym J Webb, Thomas Marjot, Jonathan A Cook, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Infection and Immunity|December 4, 2019
ZBTB7B (ThPOK) Is Required for Pathogenesis of Cerebral Malaria and Protection against Pulmonary TuberculosisJames M Kennedy, Anna Georges, Angelia V Bassenden, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Rocaglates as dual-targeting agents for experimental cerebral malariaDavid Langlais, Regina Cencic, Neda Moradin, et al.
The Journal of Experimental Medicine|November 19, 2014
CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammationJames M Kennedy, Nassima Fodil, Sabrina Torre, et al.
Nature Immunology|October 11, 2016
USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammationSabrina Torre, Maria J Polyak, David Langlais, et al.
The Lancet. Gastroenterology & Hepatology|September 1, 2020
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry studyGwilym J Webb, Thomas Marjot, Jonathan A Cook, et al.
Pageof 2